389 related articles for article (PubMed ID: 26070239)
1. Increased tonic cannabinoid CB1R activity and brain region-specific desensitization of CB1R Gi/o signaling axis in mice with global genetic knockout of monoacylglycerol lipase.
Navia-Paldanius D; Aaltonen N; Lehtonen M; Savinainen JR; Taschler U; Radner FP; Zimmermann R; Laitinen JT
Eur J Pharm Sci; 2015 Sep; 77():180-8. PubMed ID: 26070239
[TBL] [Abstract][Full Text] [Related]
2. Brain regional cannabinoid CB(1) receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient mice.
Aaltonen N; Riera Ribas C; Lehtonen M; Savinainen JR; Laitinen JT
Eur J Pharm Sci; 2014 Jan; 51():87-95. PubMed ID: 24012970
[TBL] [Abstract][Full Text] [Related]
3. Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB₁R signaling and anxiety-like behavior.
Imperatore R; Morello G; Luongo L; Taschler U; Romano R; De Gregorio D; Belardo C; Maione S; Di Marzo V; Cristino L
J Neurochem; 2015 Nov; 135(4):799-813. PubMed ID: 26223500
[TBL] [Abstract][Full Text] [Related]
4. Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system.
Chanda PK; Gao Y; Mark L; Btesh J; Strassle BW; Lu P; Piesla MJ; Zhang MY; Bingham B; Uveges A; Kowal D; Garbe D; Kouranova EV; Ring RH; Bates B; Pangalos MN; Kennedy JD; Whiteside GT; Samad TA
Mol Pharmacol; 2010 Dec; 78(6):996-1003. PubMed ID: 20855465
[TBL] [Abstract][Full Text] [Related]
5. The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors.
Savinainen JR; Saario SM; Laitinen JT
Acta Physiol (Oxf); 2012 Feb; 204(2):267-76. PubMed ID: 21418147
[TBL] [Abstract][Full Text] [Related]
6. Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain.
Leishman E; Cornett B; Spork K; Straiker A; Mackie K; Bradshaw HB
Pharmacol Res; 2016 Aug; 110():159-172. PubMed ID: 27109320
[TBL] [Abstract][Full Text] [Related]
7. Genetic deletion of monoacylglycerol lipase alters endocannabinoid-mediated retrograde synaptic depression in the cerebellum.
Zhong P; Pan B; Gao XP; Blankman JL; Cravatt BF; Liu QS
J Physiol; 2011 Oct; 589(Pt 20):4847-55. PubMed ID: 21911610
[TBL] [Abstract][Full Text] [Related]
8. Prolonged monoacylglycerol lipase blockade causes equivalent cannabinoid receptor type 1 receptor-mediated adaptations in fatty acid amide hydrolase wild-type and knockout mice.
Schlosburg JE; Kinsey SG; Ignatowska-Jankowska B; Ramesh D; Abdullah RA; Tao Q; Booker L; Long JZ; Selley DE; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2014 Aug; 350(2):196-204. PubMed ID: 24849924
[TBL] [Abstract][Full Text] [Related]
9. Monoacylglycerol Lipase Protects the Presynaptic Cannabinoid 1 Receptor from Desensitization by Endocannabinoids after Persistent Inflammation.
Bouchet CA; McPherson KB; Coutens B; Janowsky A; Ingram SL
J Neurosci; 2023 Jul; 43(30):5458-5467. PubMed ID: 37414560
[TBL] [Abstract][Full Text] [Related]
10. Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice.
Pan B; Wang W; Zhong P; Blankman JL; Cravatt BF; Liu QS
J Neurosci; 2011 Sep; 31(38):13420-30. PubMed ID: 21940435
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor.
Wyatt RM; Fraser I; Welty N; Lord B; Wennerholm M; Sutton S; Ameriks MK; Dugovic C; Yun S; White A; Nguyen L; Koudriakova T; Tian G; Suarez J; Szewczuk L; Bonnette W; Ahn K; Ghosh B; Flores CM; Connolly PJ; Zhu B; Macielag MJ; Brandt MR; Chevalier K; Zhang SP; Lovenberg T; Bonaventure P
J Pharmacol Exp Ther; 2020 Mar; 372(3):339-353. PubMed ID: 31818916
[TBL] [Abstract][Full Text] [Related]
12. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system.
Schlosburg JE; Blankman JL; Long JZ; Nomura DK; Pan B; Kinsey SG; Nguyen PT; Ramesh D; Booker L; Burston JJ; Thomas EA; Selley DE; Sim-Selley LJ; Liu QS; Lichtman AH; Cravatt BF
Nat Neurosci; 2010 Sep; 13(9):1113-9. PubMed ID: 20729846
[TBL] [Abstract][Full Text] [Related]
13. Coordinated regulation of endocannabinoid-mediated retrograde synaptic suppression in the cerebellum by neuronal and astrocytic monoacylglycerol lipase.
Liu X; Chen Y; Vickstrom CR; Li Y; Viader A; Cravatt BF; Liu QS
Sci Rep; 2016 Oct; 6():35829. PubMed ID: 27775008
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice.
Roberts CJ; Stuhr KL; Hutz MJ; Raff H; Hillard CJ
Pharmacol Biochem Behav; 2014 Feb; 117():17-24. PubMed ID: 24316201
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice.
von Rüden EL; Bogdanovic RM; Wotjak CT; Potschka H
Neurobiol Dis; 2015 May; 77():238-45. PubMed ID: 25796567
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol.
Ghafouri N; Tiger G; Razdan RK; Mahadevan A; Pertwee RG; Martin BR; Fowler CJ
Br J Pharmacol; 2004 Nov; 143(6):774-84. PubMed ID: 15492019
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension.
Szekeres M; Nádasy GL; Turu G; Soltész-Katona E; Benyó Z; Offermanns S; Ruisanchez É; Szabó E; Takáts Z; Bátkai S; Tóth ZE; Hunyady L
Mol Cell Endocrinol; 2015 Mar; 403():46-56. PubMed ID: 25595485
[TBL] [Abstract][Full Text] [Related]
18. A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis.
Hernández-Torres G; Cipriano M; Hedén E; Björklund E; Canales Á; Zian D; Feliú A; Mecha M; Guaza C; Fowler CJ; Ortega-Gutiérrez S; López-Rodríguez ML
Angew Chem Int Ed Engl; 2014 Dec; 53(50):13765-70. PubMed ID: 25298214
[TBL] [Abstract][Full Text] [Related]
19. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184.
Feliszek M; Bindila L; Lutz B; Zimmer A; Bilkei-Gorzo A; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):603-12. PubMed ID: 26984820
[TBL] [Abstract][Full Text] [Related]
20. Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue.
Pasquarelli N; Porazik C; Hanselmann J; Weydt P; Ferger B; Witting A
Neuropharmacology; 2015 Apr; 91():148-56. PubMed ID: 25497453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]